Elekta nets FDA OK for VMAT update

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Elekta has received FDA 510(k) clearance for a volumetric modulated arc therapy (VMAT) enhancement to Monaco, its radiation therapy treatment planning solution.

According to the Stockholm, Sweden-based company, the Monaco system introduces a set of tools to make the treatment planning process easier. Its intensity modulated radiotherapy (IMRT) treatment planning system features constrained optimization and dose calculation algorithms.

Monaco has been available for use clinically for the past two years for step-and-shoot IMRT planning. The product was developed in cooperation with Eberhard Karls University Tuebingen in Germany.